EAM
IMNM icon

Erste Asset Management’s Immunome IMNM Stock Holding History

Erste Asset Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1M Hold
52,000
– – 0.01% 444
2025
Q4 		$1.12M Buy
+52,000
New +$913K 0.01% 426

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Erste Asset Management's IMNM Position: Q1 2026 in Review

Erste Asset Management held its Immunome (IMNM) position steady in Q1 2026 at 52,000 shares worth $1M. The position accounts for 0.01% of the portfolio, ranked #444.

Erste Asset Management first reported a position in IMNM in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.12M in Q4 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Erste Asset Management held 52,000 shares of Immunome worth $1M as of Q1 2026.
  • Erste Asset Management left its Immunome share count unchanged in Q1 2026.
  • Immunome made up 0.01% of Erste Asset Management's portfolio in Q1 2026, its #444 holding.
  • Erste Asset Management first reported a position in Immunome in Q4 2025 and has held it in 2 quarters since.
  • Erste Asset Management's Immunome position peaked at $1.12M in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Erste Asset Management's 13F filing for Q1 2026, filed 11 May 2026.